The Kidney Disease: Improving Global Outcomes (KDIGO) 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease (CKD) represents a focused update of the KDIGO 2020 guideline on the topic. The guideline targets a broad audience of clinicians treating people with diabetes and CKD. ...
Cheung, Alfred;
Chag, Tara;
Cushman, William;
Furth, Susan;
Hou, Fan;
Ix, Joachim;
Knoll, Gregory;
Muntner, Paul;
Pecoits-Filho, Roberto;
Sarnak, Mark;
Tobe, Sheldon;
Tomson, Charles;
Lytvyn, Lyubov;
Craig, Jonathan;
Tunnicliffe, David;
Howell, Martin;
Tnoelli, Marcelo;
Cheung, Michael;
Earley, Amy;
Mann, Johannes.
The Kidney Disease: Improving Global Outcomes (KDIGO) 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease for patients not receiving dialysis represents an update to the KDIGO 2012 guideline on this topic. Development of this guideline update followed a rigorou...
Lok, Charmaine E;
Huber, Thomas S;
Lee, Timmy;
Shenoy, Surendra;
Yevzlin, Alexander S;
Abreo, Kenneth;
Allon, Michael;
Asif, Arif;
Astor, Brad C;
Glickman, Marc H;
Graham, Janet;
Moist, Louise M;
Rajan, Dheeraj K;
Roberts, Cynthia;
Vachharajani, Tushar J;
Valentini, Rudolph P.
The National Kidney Foundation’s Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidencebased guidelines for hemodialysis vascular access since 1996. Since the last update in 2006, there has been a
great accumulation of new evidence and sophistication in the guidelines process. The 201...
The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (KDOQI) has provided evidence-based guidelines for all stages of chronic kidney disease (CKD) and related complications since 1997. The 2015 update of the KDOQI Clinical Practice Guideline for Hemodialysis Adequacy is intended to...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Renal Insufficiency, Chronic/diagnosis,
Renal Insufficiency, Chronic/drug therapy,
Disease Progression,
Triage,
Angiotensin Receptor Antagonists/therapeutic use,
Angiotensin-Converting Enzyme Inhibitors/therapeutic use,
Antihypertensive Agents/therapeutic use,
Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use,
Hypolipidemic Agents/therapeutic use,
Gemfibrozil/therapeutic use,
Asymptomatic Diseases,
Drug Therapy, Combination,
GRADE Approach